Latest news articles

Added 10 months ago Drug news

Soligenix reports enrollment stage for its pivotal phase III trial of SGX 942 for oral mucositis in head and neck cancer

Soligenix announced that it has reached a significant milestone in the Phase III clinical study (the "DOM-INNATE" study) for SGX...

Added 11 months ago Drug news

Innovation Pharma seeks guidance from EMA for Brilacidin oral rinse in a Phase III program of severe Oral Mucositis

Innovation Pharmaceuticals, informs shareholders that necessary documentation has been completed for the European Medicines Agency (EMA) March 15, 2019 submission...

Added 1 year ago Drug news

FDA approves Xeomin for chronic sialorrhea.- Merz.

The FDA has approved Xeomin (incobotulinumtoxinA), from Merz, for the treatment of chronic sialorrhea (excessive drooling) due to Parkinson’s Disease...

Search all news articles for Diseases of mouth, excluding dental

Learning Zones

An Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Inflammatory Bowel Disease Knowledge Centre

Inflammatory Bowel Disease Knowledge Centre

The Inflammatory Bowel Disease (IBD) Knowledge Centre contains key information relating to the epidemiology and pathophysiology of Crohn’s disease and ulcerative colitis, highlighting prevalence, impact and unmet needs and the underlying inflammatory processes that drive IBD, considering some of the key inflammatory pathways.

Inflammatory bowel disease assessment tools

Inflammatory bowel disease assessment tools

'New IBD assessment tools at a glance' - an educational symposium sponsored by Sandoz.

Load more